16-56667360-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001301267.2(MT1G):c.49G>A(p.Ala17Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000477 in 1,614,086 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001301267.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT1G | ENST00000379811.4 | c.49G>A | p.Ala17Thr | missense_variant | Exon 2 of 3 | 1 | NM_001301267.2 | ENSP00000369139.4 | ||
MT1G | ENST00000444837.6 | c.46G>A | p.Ala16Thr | missense_variant | Exon 2 of 3 | 1 | ENSP00000391397.2 | |||
MT1G | ENST00000568675.1 | n.74G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
MT1G | ENST00000569500.5 | c.29-390G>A | intron_variant | Intron 1 of 1 | 3 | ENSP00000456675.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251424Hom.: 1 AF XY: 0.0000368 AC XY: 5AN XY: 135910
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461892Hom.: 1 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 727246
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.46G>A (p.A16T) alteration is located in exon 2 (coding exon 2) of the MT1G gene. This alteration results from a G to A substitution at nucleotide position 46, causing the alanine (A) at amino acid position 16 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at